The story so far
written Oct 30What is happening
Bayer AG secured a unanimous jury verdict in a St. Louis circuit court on October 29, 2026, defeating claims that its Roundup herbicide was defectively designed 29. The outcome impacts the company's effort to resolve approximately 65,000 existing and future U.S. claims through a proposed $7.25 billion class action settlement 34. Three women in the trial alleged the product was unreasonably dangerous and caused their non-Hodgkin lymphoma, but the jury found in favor of the company 23.
This proceeding was the first courtroom test of design-defect claims following a June 25, 2024, U.S. Supreme Court ruling that effectively blocked lawsuits based on failure-to-warn theories 25. Bayer maintains that glyphosate is safe and does not cause cancer 3. The $7.25 billion settlement remains under review by a St. Louis state court following a hearing on September 14, 2026, where plaintiffs' attorneys argued against the proposed framework 411.
What to watch
A final verdict issued in the Missouri Roundup trial would conclude the current circuit court proceedings. A filing by Bayer to the Missouri Court of Appeals would initiate a challenge to any unfavorable elements of the trial, while a written decision from the appellate court would establish the next legal precedent for design-defect claims. A final ruling from the Missouri Supreme Court or U.S. Supreme Court, or the announcement of a settlement, would resolve the pending litigation.
Read the full brief · how we got here
How we got here
The U.S. Supreme Court ruled 7-2 earlier this year against a Missouri plaintiff, finding that federal law barred claims alleging Bayer failed to include cancer warnings on Roundup labels 5. That June 25, 2024, decision shifted the litigation environment toward design-defect arguments 25. A St. Louis state court heard arguments from supporters and objectors regarding the $7.25 billion settlement deal on September 14, 2026, but did not issue an immediate ruling 4.
References · 6
- 2bloomberg.com — Bayer Wins St. Louis Roundup Trial, Bolstering Settlement Push
- 3insurancejournal.com — Bayer Faces Trial Test of Remaining Roundup Claims After Supreme Court Win
- 4claimsjournal.com — Bayer Faces Test of $7.25B Roundup Settlement In Missouri Court
- 5cnn.com — Roundup: Supreme Court tosses $1.25 million verdict for man who says ...
- 9bayer.com — Monsanto unanimously wins first Roundup™ trial since U.S ... - Bayer
- 11harmreport.com — Bayer - Objectors Challenge $7.25B Roundup Deal in Court
What would close this
0 of 4 metTimeline
1newest firstWhen we started following: Bayer wins St. Louis Roundup trial following Supreme Court ruling as $7.25 billion settlement awaits Missouri court approval
Bayer AG won a unanimous jury verdict in a St. Louis circuit court on October 29, 2026, defeating claims that its Roundup herbicide was defectively designed 2. The trial involved three women who alleged the product was unreasonably dangerous and caused their non-Hodgkin lymphoma 23. This proceeding served as the first courtroom test of design-defect claims since a June 25, 2024, U.S. Supreme Court ruling effectively blocked lawsuits based on failure-to-warn theories 25.
Separately, a $7.25 billion class action settlement intended to resolve approximately 65,000 existing and future U.S. claims is currently under review by Judge Timothy Boyer in a St. Louis state court 34. During a hearing on September 14, 2026, the court heard arguments from supporters of the deal and objections from plaintiffs' attorneys who argued against the proposed framework 4. The court did not issue an immediate ruling on the settlement's approval 4.
The litigation environment shifted earlier this year when the U.S. Supreme Court ruled 7-2 against a Missouri plaintiff, finding that federal law barred claims alleging Bayer failed to include cancer warnings on Roundup labels 5. Bayer continues to deny all claims, maintaining that glyphosate is safe and does not cause cancer 3.